Month: May 2022

San Diego, California, May 25, 2022 (GLOBE NEWSWIRE) — HUMBL, Inc. (OTC Markets: HMBL) announced today that it has completed the integration of the Polygon sidechain into HUMBL’s NFT platform, which will help creators more easily deliver NFTs to their collectors while reducing gas fees and minting costs. As a Layer 2 solution built on Ethereum, the Polygon sidechain allows users to conduct most transactions on the Ethereum blockchain for, in most cases, a fraction of the cost, and with greater speed than the Ethereum mainchain. NFTs are unique non-fungible, cryptographic tokens that reside on a blockchain which cannot be replicated, enabling creators to tokenize their intellectual property or work product so that it can be bought, sold and traded in new ways on the blockchain. “We believe NFTs are still in the very early stages...

  NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, May 25, 2022 (GLOBE NEWSWIRE) — Karora Resources Inc. (TSX:KRR; OTCQX:KRRGF) (“Karora” or the “Corporation”) is pleased to announce that it has amended the terms of its previously announced bought deal financing to increase the size of the offering to C$60,000,000 (the “Upsized Offering”). Under the terms of the Upsized Offering, Haywood Securities Inc. (“Haywood”), as co-lead underwriter and sole bookrunner, and Cormark Securities Inc. (together with Haywood, the “Co-Lead Underwriters”), as co-lead underwriter, on their own behalf and on behalf of a syndicate of underwriters (together with the Co-Lead Underwriters, the “Underwriters”), have agreed to purchase, on a bought deal basis, 12,500,000 common...

Atlanta, GA, May 25, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company specializing in developing human vaccines and cancer immunotherapies, announced today that it has entered into a definitive agreement with a single healthcare-focused institutional investor for the issuance and sale of 3,030,304 shares of common stock at a purchase price of $1.65 per share (or pre-funded warrant in lieu thereof) in a registered direct offering priced at a premium to market under Nasdaq rules. In a concurrent private placement, GeoVax has also agreed to issue and sell to the investor 9,090,910 shares of common stock (or common stock equivalents) at the same purchase price as in the registered direct offering.  In addition, the Company has agreed to issue to the investor in the offerings...

Board of Directors Recommends that Shareholders vote FOR the Arrangement TORONTO, May 25, 2022 (GLOBE NEWSWIRE) — Points.com Inc. (TSX: PTS) (NASDAQ: PCOM) (“Points” or the “Company”), the global leader in powering loyalty commerce, is pleased to announce that it has filed and is in the process of mailing the management proxy circular (the “Circular”) and related materials for the special meeting (the “Meeting”) of the Company’s shareholders (the “Shareholders”) to be held on June 23, 2022, to approve the previously announced plan of arrangement under the Canada Business Corporations Act (the “Arrangement”), pursuant to which a wholly-owned subsidiary (the “Purchaser”) of Plusgrade L.P. (“Plusgrade”), a leading ancillary revenue platform for the global travel industry, will acquire all of the issued and outstanding common shares...

BROOMFIELD, Colo., May 25, 2022 (GLOBE NEWSWIRE) — via InvestorWire — Industrial Nanotech Inc, (Pink Sheets: INTK), a global nanoscience solutions and research leader, today announces the launch of a stock buyback program effective June 1, 2022. The purpose of the program is to reduce the total amount of issued and outstanding shares of common stock of the Company, enhance shareholder value, and strategically position the Company for up-listing to a more senior exchange in early 2023. The stock buyback program will allow Industrial Nanotech Inc. to repurchase shares of the Company’s common stock. The frequency and amount of the stock buyback will be determined by U.S. Securities and Exchange Commission (SEC) regulations and revenue. The decision to execute the stock buyback program in 2022 instead of 2023 is a result of the...

Data from three trials of UV1 show dynamic T cell responses, lasting up to 7.5 years UV1-specific immune responses associated with longer clinical survival Synergy between UV1 vaccination and checkpoint inhibitionOslo, 25 May 2022: Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical stage leader in immune stimulatory vaccines for cancer, announced the publication of long-term follow-up data on UV1 in the Journal for ImmunoTherapy of Cancer (JITC). The data show that dynamic UV1 specific immune responses last up to 7.5 years, are associated with longer survival and are enhanced when UV1 is used in combinations with checkpoint inhibitors. “It is important to be able to share this validating data with our research and clinical colleagues through JITC. The data demonstrate highly durable UV1-induced immune responses that are...

Nokia CorporationManagers’ transactions25 May 2022 at 19:40 EEST Nokia Corporation – Managers’ transactions (Guillén) Transaction notification under Article 19 of EU Market Abuse Regulation. ____________________________________________Person subject to the notification requirementName: Guillén, FedericoPosition: Other senior manager Issuer: Nokia CorporationLEI: 549300A0JPRWG1KI7U06Notification type: INITIAL NOTIFICATIONReference number: 15574/5/4____________________________________________ Transaction date: 2022-05-25Venue not applicableInstrument type: SHAREISIN: FI0009000681Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details(1): Volume: 37736 Unit price: N/A Aggregated transactions(1): Volume: 37736 Volume weighted average price: N/A About NokiaAt Nokia, we create technology that helps the world...